Detalhe da pesquisa
1.
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia.
Haematologica
; 109(1): 60-71, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345475
2.
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
J Allergy Clin Immunol
; 151(2): 485-493.e11, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309122
3.
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.
Int J Mol Sci
; 23(15)2022 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955907
4.
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.
Hematol Oncol
; 42(3): e3277, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682493
5.
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.
Ther Adv Hematol
; 14: 20406207231205643, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929078